Showing results (981-990 of 4,874) with videos related to
Sort By:
Pageof 488
Urologic Oncology|January 21, 2014
The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancerUlrika Segersten, Yael Spector, Yaron Goren, et al.Urologic Oncology|January 22, 2014
Commentary on "circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer." Szarvas T, Jäger T, Laszlo V, Kramer G, Klingler HC, vom Dorp F, Romics I, Ergün S, Rübben H, Department of Urology, University of Duisburg-Essen, Germany.: J Urol 2012;80(3):13-8 [Epub 2012 May 17]Douglas S ScherrUrologic Oncology|June 18, 2014
The role of microRNA in castration-resistant prostate cancerWilliam Thieu, Derya Tilki, Ralph de Vere White, et al.Urologic Oncology|June 18, 2014
Adherence to surveillance guidelines after radical cystectomy: a population-based analysisBehfar Ehdaie, Coral L Atoria, William T Lowrance, et al.Urologic Oncology|June 22, 2014
Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomyTakuya Koie, Chikara Ohyama, Hayato Yamamoto, et al.Urologic Oncology|June 24, 2014
Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?Hristos Z Kaimakliotis, M Francesca Monn, K Clint Cary, et al.Urologic Oncology|January 9, 2014
Prognostic significance of indeterminate lung nodules in renal cell carcinomaRena Xu, Nora Horick, Francis J McGovern, et al.Urologic Oncology|January 9, 2014
Highlights from the first symposium on upper tract urothelial carcinomaSurena F Matin, Shahrokh F Shariat, Matthew I Milowsky, et al.Urologic Oncology|July 5, 2014
Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and densityZai-shang Li, Kai Yao, Peng Chen, et al.Pageof 488